Duration: The study is anticipated to span over 12-18 months depending on eligibility.
Assessments: Participants will be required to keep a headache diary to track their migraine episodes. They will also attend regular clinic visits for assessments, which may include physical examinations, vital sign measurements, ECGs, and laboratory tests.
Ethical Considerations: The study will be conducted in compliance with applicable ethical and regulatory standards. All study participation is voluntary. Informed consent will be obtained from both the participants and their legal guardians.
Compensation: Participants will receive compensation for their time and travel expenses related to study visits. Inquire with study staff for more information regarding these details.
These criteria are designed to ensure that the participants in the study are representative of the population the investigational drug is intended to help.
